Bristol Myers Squibb and Nektar have read the last rites to their huge, failed cancer collaboration. With two more late-stage trials failing, the partners have ended clinical development of a ...
MedPage Today on MSN
Immuno-oncology tops embolization for intermediate-grade liver cancer
SAN FRANCISCO -- An immuno-oncology (IO) regimen for intermediate-stage hepatocellular carcinoma (HCC) significantly extended ...
Driven by a paradigm shift to curative early-stage interventions and surging ADC demand, the market offers massive upside.
There's mounting research to suggest that protecting people who are immuno-compromised from getting COVID is important not just for their sake – it could be critical in the effort to end the pandemic ...
Cancer is a highly complex disease that tends to be caused by the overgrowth of malignant cells and altered immune response. Traditional cancer therapies include surgery, radiotherapy, chemotherapy, ...
Immunotherapy is proving a massive draw for investors and big pharma companies alike. These privately-owned immuno-oncology startups have bagged hefty funding rounds in the last two years. For decades ...
This is the latest partnership for PharmaJet. Immuno Cure BioTech and PharmaJet are working together on a clinical study to test the effectiveness of PharmaJet’s needle-free vaccine delivery system ...
The aggressive brain cancer glioblastoma is infamously “cold” when it comes to immunotherapy, meaning it typically doesn’t respond to immune-boosting therapies because of immune-suppressing molecules ...
First developed in 1992, immuno-PCR combines an ELISA (enzyme-linked immunosorbent assay) with PCR (polymerase chain reaction) to offer a significant increase in sensitivity compared with traditional ...
A sensor identifies misfolded protein biomarkers in the blood. This offers a chance to detect Alzheimer's disease before any symptoms occur. Researchers intend to bring it to market maturity. The ...
Immuno-spin trapping is a highly sensitive method for detecting DNA radicals in biological systems. This technique involves three main steps: (i) in situ and real-time trapping of DNA radicals with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback